{"DataElement":{"publicId":"3113169","version":"1","preferredName":"Disease Progression Assessment Type","preferredDefinition":"the type related to determination of resul for the worsening of a disease over time.","longName":"3113164v1.0:3113165v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"3113164","version":"1","preferredName":"Disease Progression Assessment","preferredDefinition":"information related to determination of resul for the worsening of a disease over time.","longName":"2425498v1.0:2233077v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2425498","version":"1","preferredName":"Disease Progression","preferredDefinition":"Cancer that continues to grow or spread.","longName":"C17747","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Progression","conceptCode":"C17747","definition":"A process that manifests as the worsening of a disease over time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"03E16831-B464-6D9B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-11-02","modifiedBy":"ONEDATA","dateModified":"2005-11-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233077","version":"1","preferredName":"Assessment","preferredDefinition":"The final result of a determination of the value, significance, or extent of.","longName":"C25367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Assessment","conceptCode":"C25367","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F90B5E56-BAFE-0F45-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-08","modifiedBy":"ONEDATA","dateModified":"2005-06-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"897022B4-0F58-29BB-E040-BB89AD4317F6","latestVersionIndicator":"Yes","beginDate":"2010-06-20","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-20","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3113165","version":"1","preferredName":"Disease Progression Assessment Type","preferredDefinition":"the type of assessment of disease progression.","longName":"3113165v1.0","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"by PSA","valueDescription":"PSA","ValueMeaning":{"publicId":"3113166","version":"1","preferredName":"PSA","longName":"3113166","preferredDefinition":"Alternate isoforms of the single-chain 261-aa 30-kD Kallikrein 3 (Prostate Specific Antigen) glycoprotein precursor are encoded by human KLK3 Gene (Kallikrein Family). Frameshifted isoform 2 has a shorter distinct C-terminus. A serine protease in seminal plasma, PSA may function in liquefaction of seminal coagulum by (preferential Tyr-X) cleavage of seminal vesicle protein. Kallikrein proteases have diverse functions. Mounting evidence implicates kallikreins in carcinogenesis; some have potential as cancer biomarkers. The serum level of PSA is useful in diagnosis and monitoring of prostatic carcinoma. (from LocusLink, Swiss-Prot, OMIM, and NCI)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate-Specific Antigen","conceptCode":"C17525","definition":"Prostate-specific antigen (261 aa, ~29 kDa) is encoded by the human KLK3 gene. This protein plays a role in both proteolysis and seminal fluid liquefaction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"897022B4-0F80-29BB-E040-BB89AD4317F6","latestVersionIndicator":"Yes","beginDate":"2010-06-20","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"897022B4-0F99-29BB-E040-BB89AD4317F6","beginDate":"2010-06-20","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-20","modifiedBy":"ONEDATA","dateModified":"2010-06-20","deletedIndicator":"No"},{"value":"by radiographic criteria","valueDescription":"Radiograph","ValueMeaning":{"publicId":"3113167","version":"1","preferredName":"Radiograph","longName":"3113167","preferredDefinition":"An image produced on a radiosensitive surface by x-ray radiation that has penetrated and passed through a structure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radiograph","conceptCode":"C60727","definition":"An image produced on a radiosensitive surface by x-ray radiation that has penetrated and passed through a structure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"897022B4-0FA5-29BB-E040-BB89AD4317F6","latestVersionIndicator":"Yes","beginDate":"2010-06-20","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"897022B4-0FBE-29BB-E040-BB89AD4317F6","beginDate":"2010-06-20","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-20","modifiedBy":"ONEDATA","dateModified":"2010-06-20","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"897022B4-0F6A-29BB-E040-BB89AD4317F6","latestVersionIndicator":"Yes","beginDate":"2010-06-20","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-20","modifiedBy":"ALAIS","dateModified":"2010-06-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Disease progression","type":"Preferred Question Text","description":"Disease progression","url":null,"context":"CTEP"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"897022B4-0FC8-29BB-E040-BB89AD4317F6","latestVersionIndicator":"Yes","beginDate":"2010-06-20","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-20","modifiedBy":"ALAIS","dateModified":"2010-06-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}